Related Experiment Videos
Alternate splicing in human Na+-MI cotransporter gene yields differentially regulated transport isoforms
F Porcellati1, Y Hosaka, T Hlaing
1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0354, USA.
The American Journal of Physiology
|June 11, 1999
Summary
Na+-myo-inositol cotransporters (SMIT) regulate intracellular myo-inositol levels. Novel SMIT isoforms generated by alternative splicing may explain variations in SMIT structure and regulation across tissues and species.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- myo-Inositol is vital for cellular function, acting as an osmolyte and phosphoinositide precursor.
- Na+-myo-inositol cotransporters (SMIT) maintain millimolar intracellular myo-inositol concentrations.
- SMIT activity and transcript expression show variability across mammalian tissues and species.
Purpose of the Study:
- To investigate the molecular basis for observed heterogeneity in SMIT structure and regulation.
- To identify novel mechanisms generating SMIT diversity.
- To explore the functional implications of alternative splicing in SMIT gene expression.
Main Methods:
- Functional cloning and expression of canine SMIT cDNA in Xenopus oocytes.
- Analysis of SMIT transcript arrays in various mammalian cells and species.
- Investigation of alternative splicing events in human SMIT gene expression using human retinal pigment epithelial cells.
Main Results:
- A canine SMIT cDNA predicted a 718-amino acid peptide homologous to Na+-glucose cotransporters, with potential phosphorylation sites.
- Osmotic induction of diverse SMIT transcripts (1.0-13.5 kb) was observed in mammalian cells.
- Alternative splicing, including the use of a novel splice donor site within the coding region, generates SMIT isoforms with altered C-termini and potential phosphorylation sites.
Conclusions:
- Alternative splicing within the SMIT coding region can generate novel isoforms with distinct intracellular C-termini.
- These novel isoforms possess unique phosphorylation sites (Protein Kinase A and C), potentially explaining functional heterogeneity.
- The findings provide insight into the structural and regulatory diversity of Na+-myo-inositol cotransporters.